Pembrolizumab and Chemotherapy Neoadjuvant/Adjuvant of NSCLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
Immunity in Persons Fully Vaccinated Against Measles, Mumps and Rubella and Responses to Booster Vaccination
- Status
- RECRUITING
- Phase
- PHASE3
A Study To Evaluate The Effect Of A Supratherapeutic Dose Of Elpipodect (MK-8189) On The QTc Interval In Participants With Schizophrenia (MK-8189-019)
- Status
- COMPLETED
- Phase
- PHASE1
Group Intervention on Vaccine Confidence
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Sugammadex vs Neostigmine/Glycopyrrolate on Urinary Retention After Spine Surgery
- Status
- COMPLETED
- Phase
- PHASE4
Feasibility and Impact of Liquid Biopsy Genomic Profiling on Treatment Patients With Metastatic Prostate Cancer in Spain (SOLTI-2102)
- Status
- RECRUITING
- Phase
- N/A
Pembrolizumab and EV With Radiation Therapy for MIBC Patients (PEVRAD)
- Status
- RECRUITING
- Phase
- PHASE2
Randomized Study of Neo-adjuvant and Adjuvant Pembrolizumab With and Without Targeted Blood Brain Barrier Opening Using Exablate MRI-guided Focused Ultrasound (Exablate MRgFUS) for Recurrent Glioblastoma
- Status
- WITHDRAWN
- Phase
- PHASE2
A Clinical Study of Efinopegdutide in Participants With Precirrhotic Nonalcoholic Steatohepatitis (NASH) (MK-6024-013)
- Status
- COMPLETED
- Phase
- PHASE2
Study of WM-A1-3389 in Participants With Advanced or Metastatic Solid Tumors and Non-Small Cell Lung Cancer (MK-3475-E90/KEYNOTE-E90)
- Status
- RECRUITING
- Phase
- PHASE1
App and Body Fat Scale in the Management of Overweight Patients
- Status
- RECRUITING
- Phase
- NA
Testing Experimental Anti-cancer Drug SLC-391 With an Approved Immunotherapy Drug, Pembrolizumab, for Advanced Lung Cancers
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Phase 1 Study of ZL-1218 in Subjects With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Study of MK-0472 in Participants With Advanced/Metastatic Solid Tumors (MK-0472-001)
- Status
- RECRUITING
- Phase
- PHASE1
Pembrolizumab in High-risk Thyroid Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Efficacy and Safety of Pembrolizumab Plus Enfortumab Vedotin (EV) +/- Investigational Agents in First-Line Metastatic Urothelial Carcinoma (mUC) (MK-3475-04B/KEYMAKER-U04)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
First-line CBDCA/PTX/LEN/Pembrolizumab Combination for Previously Untreated Advanced or Recurrent Thymic Carcinomas (Artemis)
- Status
- RECRUITING
- Phase
- PHASE2
Project PEER: Understanding the Lung Cancer Patient ExperiEnce in the Real-World Setting
- Status
- RECRUITING
- Phase
- N/A
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Safety, Tolerability, Pharmacokinetics (PK), and Food Effect of MK-7762 in Healthy Adults
- Status
- COMPLETED
- Phase
- PHASE1